Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus

Clinical Immunology and Immunopathology

Volumn 81, Issue 3, 1996, Pages 239-243

  Font, J ^a   Pallares, L ^a   Martorell, J ^a   Martinez, E ^a   Gaya, A ^a   Vives, J ^a   Ingelmo, M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030560752     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0184     Document Type: Article

References (29)

1. 1. McMichael, A. J., and Goth, F. M. T-cell antigens: New and previously defined clusters. In "Leucocyte Typing III" (A. J. McMichael, S. Cobbold, M. J. Crumpton, W. Gilks, F. M. Gotch, N. Hogg, M. Horton, N. Ling, I. C. M. McLennan, D. Y., Mason C. Milstein, D. Spiegelhalter, and H. Waldmann, Eds.), p. 31, Oxford Univ. Press, London, 1987.
2. 2. Van Lier, R. A. W., Borst, J., Vroom, T. M., et al., Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139, 1589-1596, 1987.
3. 3. Borst, J., Sluyser, C., De Vries, E., et al., Alternative molecular form of human T cell-specific antigen CD27 expressed upon T cell activation. Eur. J. Immunol. 19, 357-364, 1989.
4. 4. Martorell, J., Rojo, I., Vilella, R., Martínez-Cáceres, E., and Vives, J., CD27 induction on thymocytes. J. Immunol. 145, 1356-1363, 1990.
5. 5. Camerini, D., Walz, G., Loenen, W. A. M., Borst, J., and Seed, B., The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 147, 3165-3169, 1991.
6. 6. De Jong, R., Loenen, W. A. M., Brouwer, M., et al., Regulation of expression of CD27, a T cell-specific member of a novel family of membrane receptors. J. Immunol. 146, 2488-2494, 1991.
7. 7. Loenen, W. A. N., De Jong, R., Gravenstein, L. A., Van Lier, R. A. W., and Borst, J. The T cell activation molecule CD27 is a member of the nerve growth factor receptor gene family. In "Biological Signal Transduction, NATO Series" (Ross E. M. Witzkwa, Ed.), Vol. H52, p. 131, Spunger Vedag, Berlin.
8. 8. Hintzen, R. Q., De Jong, R., Hack, C. E., et al., A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J. Immunol. 147, 29-35, 1991.
9. 9. Engelmann, H., Novick, D., and Wallach, W., Two tumor necrosis factor-binding proteins purified from human urine. J. Biol. Chem. 265, 1531-1536, 1990.
10. 10. Novick, D., Engelmann, H., Wallach, D., and Rubinstein, M., Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170, 1409-1414, 1989.
11. 11. Fernandez-Botran, R., and Vitetta, E. S., A soluble high affinity interleukin-4-binding protein is present in biological fluids of mice. Proc. Natl. Acad. Sci. USA 87, 4202-4206, 1990.
12. 12. Maliszewski, C. R., Sato, T. A., Vandenbos, T., et al., Recombinant soluble receptors specifically inhibit IL-1 and IL-4 induced B-cell activities in vitro. J. Immunol. 144, 3028-3033, 1990.
13. 13. Seckinger, P., Isaaz, S., and Dayer, J. M. A human inhibitor of tumor necrosis factor alpha. J. Exp. Med. 167, 1511-1516, 1988.
14. 14. Zupan, A. A., Osborne, P. A., Smith, C. E., Siegel, N. R., Leimgruber, R. M., and Johnson, E. M., Identification, purification and characterisation of truncated forms of the human nerve growth factor receptor. J. Biol. Chem. 264, 11714-11720, 1989.
15. 15. Marcon, L., Fritz, M. E., Kurman, C. C., Jensen, J. C., and Nelson, D. L., Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia. Clin. Exp. Immunol. 73, 29, 1988.
16. 16. Hintzen, R. Q., van Lier, R. A. W., Kuijpers, K. C., et al., Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 35, 211, 1991.
17. 17. Rubin, L. A., and Nelson, D. L., The soluble interleukin-2 receptor: Biology, function and clinical application. Ann. Intern. Med. 113, 619-627, 1990.
18. 18. Rubin, L. A., Kurman, C. C., Fritz, F. E., Biddison, B. E., Boutin, B., Yarchoan, R., and Nelson, D., Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 135, 3172, 1985.
19. 19. Steinberg, A. D., Systemic lupus erythematosus: Theories of pathogenesis and approach to therapy. Clin. Immunol. Immunopathol. 72, 171-176, 1994.
20. 20. Ward, M. M., Dooley, M. A., Christenson, V. D., and Pisetsky, D. S., The relationship between soluble interleukin 2 receptor levels and antidoubled stranded DNA antibody levels in patients with systemic lupus erythematosus. J. Rheumatol. 18, 235-240, 1991.
21. 21. Raziuddin, S., Al-Janadi, M. A., and Al-Wabel, A. A., Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus. J. Rheumatol. 18, 831-836, 1991.
22. 22. Spronk, P. E., Borg, E. J., Huitema, M. G., Limburg, P. C., and Kallemberg, CGM., Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: A prospective study. Ann. Rheum. Dis. 53, 235-239, 1994.
23. 23. Pino, M. R., Viñas, O., Fuente, M. A., et al., Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. It is present in normal human serum and its levels are increased in the serum of systemic lupus erythematosus patients. J. Immunol. 154, 3015-3024, 1995.
24. 24. Tan, E. M., Cohen, A. S., Fries, J., et al., The 1982 revised criteria for classification of SLE. Arthritis Rheum. 25, 1271-1272, 1982.
25. 25. Takeuchi, T., Amano, K., Sekine, H., et al., Upregulated expression and function of integrin adhesive receptors in SLE patients with vasculitis. J. Clin. Invest. 92, 3008-3016, 1993.
26. 26. Plana, M., Font, J., Viñas, O., et al., Responsiveness of T lymphocytes from systemic lupus erythematosus to signals provided through CD26 antigen. Clin. Immunol. Immunopathol. 72, 227-232, 1994.
27. 27. Ward, M. M., Dooley, M. A., Christenson, V. D., and Pisetsky, D. S., The relationship between interleukin-2 receptor levels and antidouble stranted DNA antibody levels in patients with systemic lupus erythematosus. J. Rheumatol. 18, 235-240, 1991.
28. 28. Tortorella, C., Schulze-Koops, H., Thomas, R., Splawski, J. B., Davis, L. S., Picker, L. J., and Lipsky, P. E., Expression of CD45RB and CD27 identifies subsets of CD4+ memory T cells with different capacities to induce B cell differentiation. J. Immunol. 155, 149-62, 1995.
29. 29. Chamuleau, M. E. D., Berge, I. J. M., Schellekens, P. T. A., Wiermink, J. M., Hintzen, R. Q., and Van Lier, R. A. W., Serum levels of soluble CD27 in renal transplant recipients. Transplantation 54, 932-936, 1992.